Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Differentiated Thyroid Cancer-Treatment: State of the Art.

Schmidbauer B, Menhart K, Hellwig D, Grosse J.

Int J Mol Sci. 2017 Jun 17;18(6). pii: E1292. doi: 10.3390/ijms18061292. Review.

2.

Phenotypic predictors and final diagnoses in patients referred for RASopathy testing by targeted next-generation sequencing.

Bhoj EJ, Yu Z, Guan Q, Ahrens-Nicklas R, Cao K, Luo M, Tischler T, Deardorff MA, Zackai E, Santani AB.

Genet Med. 2017 Jun;19(6):715-718. doi: 10.1038/gim.2016.169. Epub 2016 Oct 20. Review.

PMID:
27763634
3.

A unique case of growth hormone and human chorionic gonadotropin treatment in a 45,X male with Y: autosome translocation and literature review.

Mareri A, Iezzi M, Salvatore A, Ligas C, D'Alessandro E.

J Pediatr Endocrinol Metab. 2016 Jul 1;29(7):857-62. doi: 10.1515/jpem-2015-0427. Review.

PMID:
27054600
4.

Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.

Schütte P, Möricke A, Zimmermann M, Bleckmann K, Reismüller B, Attarbaschi A, Mann G, Bodmer N, Niggli F, Schrappe M, Stanulla M, Kratz CP.

Eur J Med Genet. 2016 Mar;59(3):143-51. doi: 10.1016/j.ejmg.2015.12.008. Epub 2015 Dec 28. Review.

PMID:
26732628
5.

The impact of growth hormone therapy on adult height in noonan syndrome: a systematic review.

Giacomozzi C, Deodati A, Shaikh MG, Ahmed SF, Cianfarani S.

Horm Res Paediatr. 2015;83(3):167-76. doi: 10.1159/000371635. Epub 2015 Feb 21. Review.

6.

Malignancy in Noonan syndrome and related disorders.

Smpokou P, Zand DJ, Rosenbaum KN, Summar ML.

Clin Genet. 2015 Dec;88(6):516-22. doi: 10.1111/cge.12568. Epub 2015 Mar 4. Review.

PMID:
25683281
7.

The efficacy and safety of growth hormone therapy in children with noonan syndrome: a review of the evidence.

Noonan JA, Kappelgaard AM.

Horm Res Paediatr. 2015;83(3):157-66. doi: 10.1159/000369012. Epub 2014 Dec 10. Review.

8.

Structure, function, and pathogenesis of SHP2 in developmental disorders and tumorigenesis.

Huang WQ, Lin Q, Zhuang X, Cai LL, Ruan RS, Lu ZX, Tzeng CM.

Curr Cancer Drug Targets. 2014;14(6):567-88. Review.

PMID:
25039348
9.

Syndromic disorders with short stature.

Şıklar Z, Berberoğlu M.

J Clin Res Pediatr Endocrinol. 2014;6(1):1-8. doi: 10.4274/Jcrpe.1149. Review.

10.

SHP-2 regulates growth factor dependent vascular signalling and function.

Mannell H, Krotz F.

Mini Rev Med Chem. 2014;14(6):471-83. Review.

PMID:
22512561
11.

Chromosome 15q24 microdeletion syndrome.

Magoulas PL, El-Hattab AW.

Orphanet J Rare Dis. 2012 Jan 4;7:2. doi: 10.1186/1750-1172-7-2. Review.

12.

The benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational age.

Kappelgaard AM, Laursen T.

Growth Horm IGF Res. 2011 Dec;21(6):305-13. doi: 10.1016/j.ghir.2011.09.004. Epub 2011 Oct 20. Review.

PMID:
22019012
13.

Rosette forming glioneuronal tumor in association with Noonan syndrome: pathobiological implications.

Karafin M, Jallo GI, Ayars M, Eberhart CG, Rodriguez FJ.

Clin Neuropathol. 2011 Nov-Dec;30(6):297-300. Review.

14.

[Rasopathies: developmental disorders that predispose to cancer and skin manifestations].

Hernández-Martín A, Torrelo A.

Actas Dermosifiliogr. 2011 Jul-Aug;102(6):402-16. doi: 10.1016/j.ad.2011.02.010. Epub 2011 May 4. Review. Spanish.

PMID:
21536246
15.

The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years.

Wilkinson JD, Landy DC, Colan SD, Towbin JA, Sleeper LA, Orav EJ, Cox GF, Canter CE, Hsu DT, Webber SA, Lipshultz SE.

Heart Fail Clin. 2010 Oct;6(4):401-13, vii. doi: 10.1016/j.hfc.2010.05.002. Review.

16.

Evo-Devo of child growth III: premature juvenility as an evolutionary trade-off.

Hochberg Z.

Horm Res Paediatr. 2010;73(6):430-7. doi: 10.1159/000282109. Epub 2010 Apr 15. Review.

17.

GH therapy in Noonan syndrome: Review of final height data.

Dahlgren J.

Horm Res. 2009 Dec;72 Suppl 2:46-8. doi: 10.1159/000243779. Epub 2009 Dec 22. Review.

PMID:
20029237
18.

Abnormal growth in noonan syndrome: the challenge of optimal therapy.

Savage MO, Padidela R, Kirk JM, Malaquias AC, Jorge AA.

Pediatr Endocrinol Rev. 2009 Jun;6 Suppl 4:523-8. Review.

PMID:
19550387
19.

Coronary artery dilatation in LEOPARD syndrome. A child case and literature review.

Iwasaki Y, Horigome H, Takahashi-Igari M, Kato Y, Razzaque MA, Matsuoka R.

Congenit Heart Dis. 2009 Jan-Feb;4(1):38-41. doi: 10.1111/j.1747-0803.2008.00243.x. Review.

PMID:
19207402
20.

Noonan syndrome caused by germline KRAS mutation in Taiwan: report of two patients and a review of the literature.

Lo FS, Lin JL, Kuo MT, Chiu PC, Shu SG, Chao MC, Lee YJ, Lin SP.

Eur J Pediatr. 2009 Aug;168(8):919-23. doi: 10.1007/s00431-008-0858-z. Epub 2008 Oct 29. Review.

PMID:
18958496

Supplemental Content

Loading ...
Support Center